Skip to main content
. 2021 May 13;10(10):2107. doi: 10.3390/jcm10102107

Figure 1.

Figure 1

Current MDS treatment. MDS: myelodysplastic syndrome; int: intermediate; MDS-RS: a myelodysplastic syndrome with ring sideroblast; EPO: erythropoietin; HMA: hypomethylating agents.